Small bowel
PROFILE follow-up links anti-TNF at diagnosis to fewer Crohn's surgeries

  • October 9

Stomach
Perioperative durvalumab improved survival in phase 3 gastric cancer trial

  • October 8

Small Talk, Big Topics podcast returns for season 4

  • October 8

Colon
Ductal extension, cancer risk shape AGA advice on ampullary adenomas

  • October 7

Colon

Multiple affected relatives linked to higher CRC risk in IBD

  • October 9

Patients with at least two first-degree relatives with colorectal cancer had 2.59 times the colorectal cancer rate of those with no family history in a Swedish cohort of more than 124,000 patients.

BROWSE BY TOPICS

The New Gastroenterologist

Substance use disorders in gastroenterology and hepatology: A practical guide for the general gastroenterologist

  • August 3

  • by Isabelle S. Byers, MD, Michelle Russin, MD, Sasha Deutsch-Link, MD, MSCR

GI and liver complications often bring these patients in first, and the authors say gastroenterologists are well placed to screen and treat.

Esophagus
Bridging the rural divide: Building a motility center in a critical access hospital

  • August 3

  • by Amber Charoen, MD, W. Michael McDonnell, MD, AGAF

“If large urban centers can run comprehensive motility labs, why can't a critical access hospital?”

Is professional coaching worth it? A practical guide for early-career gastroenterologists

  • August 3

  • by Mariam Naveed, MD, FACG, Kathryn E. Hutchins, MD, FACG

Two program directors on why coaching belongs at the start of a GI career, not after something has already gone wrong.

The Latest

October 9
Colon
Multiple affected relatives linked to higher CRC risk in IBD

  • by Doug Brunk

Patients with at least two first-degree relatives with colorectal cancer had 2.59 times the colorectal cancer rate of those with no family history in a Swedish cohort of more than 124,000 patients.

October 9
Small bowel
PROFILE follow-up links anti-TNF at diagnosis to fewer Crohn's surgeries

  • by Alun Evans

Over a median of about five years, 13% of patients assigned to step-up care needed Crohn's disease-related abdominal surgery, compared with 3% of those who started infliximab plus an immunomodulator at diagnosis.

October 8
Stomach
Perioperative durvalumab improved survival in phase 3 gastric cancer trial

  • by Doug Brunk

At three years, 69% of patients assigned to durvalumab plus chemotherapy were alive vs. 62% of those assigned to placebo plus chemotherapy.

October 8
Small Talk, Big Topics podcast returns for season 4

  • by AGA

Two new hosts join the new season of the podcast to discuss topics including mentorship of women in GI, providing inclusive care to LGBTQI+ patients, and more.

October 7
Colon
Ductal extension, cancer risk shape AGA advice on ampullary adenomas

  • by Doug Brunk

Adenomas extending more than 1 cm into a duct should prompt surgical consultation, the expert review suggests, while those with less extension may be managed endoscopically with close surveillance.